105 related articles for article (PubMed ID: 2471768)
1. Coagulation inhibitor levels in pneumonia and stroke: changes due to consumption and acute phase reaction.
Sandset PM; Andersson TR
J Intern Med; 1989 May; 225(5):311-6. PubMed ID: 2471768
[TBL] [Abstract][Full Text] [Related]
2. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
[TBL] [Abstract][Full Text] [Related]
3. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
[TBL] [Abstract][Full Text] [Related]
4. Acute-phase proteins in stroke: influences of its cause (cerebral hemorrhage or infarction), of the cerebral site of infarction, and of the sex of patients.
Ionescu DA; Haţegan D; Jipescu I; Steinbruch L; Scu MG
Rom J Neurol Psychiatry; 1991; 29(1-2):61-70. PubMed ID: 1716456
[TBL] [Abstract][Full Text] [Related]
5. Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.
Toulon P; Vitoux JF; Capron L; Roncato M; Fiessinger JN; Aiach M
Thromb Res; 1988 Mar; 49(5):497-500. PubMed ID: 3376055
[No Abstract] [Full Text] [Related]
6. [Observation of plasma levels of antithrombin-III and plasminogen in acute cerebrovascular disease].
Lu J
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):205-7, 252-3. PubMed ID: 2620588
[TBL] [Abstract][Full Text] [Related]
7. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
8. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
Andersson TR
Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
[TBL] [Abstract][Full Text] [Related]
9. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
10. Coagulation inhibition and activation in pancreatic cancer. Changes during progress of disease.
Lindahl AK; Odegaard OR; Sandset PM; Harbitz TB
Cancer; 1992 Oct; 70(8):2067-72. PubMed ID: 1394036
[TBL] [Abstract][Full Text] [Related]
11. [Antithrombin III and heparin cofactor II].
Kondo S; Niwa M
Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
[No Abstract] [Full Text] [Related]
12. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
13. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
14. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
15. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
16. Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT).
Tran TH; Duckert F
Thromb Res; 1985 Nov; 40(4):571-6. PubMed ID: 3841235
[No Abstract] [Full Text] [Related]
17. Haemorheological factors in the pathophysiology of acute stroke.
Thavaraj V; Behari M; Prasad K; Yadav RJ; Raina P; Ahuja GK
Neurol Res; 1992; 14(2 Suppl):92-3. PubMed ID: 1355898
[TBL] [Abstract][Full Text] [Related]
18. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
[TBL] [Abstract][Full Text] [Related]
19. Heparin cofactor II: a simple assay method and results of its clinical application.
Vinazzer H; Pangraz U
Thromb Res; 1987 Oct; 48(2):153-60. PubMed ID: 3424287
[TBL] [Abstract][Full Text] [Related]
20. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
